Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Interview about positive interim results from Phase II BCS

<< Previous

Bullboard Posts

Next >>

Comment by DJDawgon Jun 13, 2023 1:12pm

184 Views

Post# 35494075

RE:RE:RE:RE:RE:Interview about positive interim results from Phase II BCS

Completely agree. When RDW got into trouble it was for being too enthusiastic about something in terms of future success. One reason his penalty was not as big as they showed that he never sold his own stock as one would do if pumping and dumping.

In this case, the same mistake would be to over promise anything when you are dependent on the FDA for approvals.

Hopefully, underpromise and overdeliver will become the the new motto for TLT.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing